Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 29, 2021 - Issue 3
Submit an article Journal homepage
243
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor

Bilateral Drug-Induced Uveitis and Epiretinal Membrane during the Treatment of a Metastatic Cutaneous Melanoma

Marcos Mozo CuadradoOphthalmology, Complejo Hospitalario de Navarra, Pamplona, SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6026-2729
, MDORCID Icon,
Laura Tabuenca Del BarrioOphthalmology, Complejo Hospitalario de Navarra, Pamplona, Spain
, MD &
Esther Compains SilvaOphthalmology, Complejo Hospitalario de Navarra, Pamplona, Spain
, MD
Pages 543-545 | Received 11 Sep 2019, Accepted 22 Oct 2019, Published online: 22 Nov 2019

References

  • Moorthy RS, Moorthy MS, Cunningham ET Jr. Drug-induced uveitis. Curr Opin Ophthalmol. Nov, 2018;29(6):588–603. doi:10.1097/ICU.0000000000000530.
  • Trad S, Bonnet C, Monnet D. Induced drug uveitis and drug side effects in ophthalmology. Rev Med Interne. Sep, 2018;39(9):699–710. doi:10.1016/j.revmed.2018.02.017.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first International workshop. Am J Ophthalmol. Sep, 2005;140(3):509–516.
  • Long GV, Stroyakovskiy D, Gogas H, et al. Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma. N Engl J Med. Nov 13, 2014;371(20):1877–1888. doi:10.1056/NEJMoa1406037.
  • Menzies AM, Long GV. Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanoma. Clin Cancer Res. Apr 15, 2014;20(8):2035–2043. doi:10.1158/1078-0432.CCR-13-2054.
  • Huillard O, Bakalian S, Levy C, et al. Ocular adverse events of molecularly targeted agents approved in solid tumours: a systematic review. Eur J Cancer. Feb, 2014;50(3):638–648. doi:10.1016/j.ejca.2013.10.016.
  • Renouf DJ, Velazquez-Martin JP, Simpson R, Siu LL, Bedard PL. Ocular toxicity of targeted therapies. J Clin Oncol. Sep 10, 2012;30(26):3277–3286. doi:10.1200/JCO.2011.41.5851.
  • Scott LJ. Nivolumab: a review in advanced melanoma. Drugs. Aug, 2015;75(12):1413–1424. doi:10.1007/s40265-015-0442-6.
  • Karlin J, Gentzler R, Golen J. Bilateral Anterior Uveitis associated with nivolumab therapy. Ocul Immunol Inflamm. 2018;26(2):283–285. doi:10.1080/09273948.2016.1215473.
  • Lim J, Lomax AJ, McNeil C, Harrisberg B. Uveitis and papillitis in the setting of dabrafenib and trametinib therapy for metastatic melanoma: a case report. Ocul Immunol Inflamm. 2018;26(4):628–631. doi:10.1080/09273948.2016.1246666.
  • Sarny S, Neumayer M, Kofler J, El-Shabrawi Y. Ocular toxicity due to trametinib and dabrafenib. BMC Ophthalmol. Aug 17, 2017;17(1):146. doi:10.1186/s12886-017-0541-0.
  • Rémond AL, Barreau E, Le Hoang P, Bodaghi B. Bilateral uveitis associated with nivolumab therapy. J Fr Ophtalmol. Jun, 2018;41(6):536–539. doi:10.1016/j.jfo.2017.10.009.
  • Draganova D, Kerger J, Caspers L, Willermain F. Severe bilateral panuveitis during melanoma treatment by Dabrafenib and Trametinib. J Ophthalmic Inflamm Infect. Jun 9, 2015;5:17. doi:10.1186/s12348-015-0049-9.
  • Rueda-Rueda T, Sánchez-Vicente JL, Moruno-Rodríguez A, Molina-Socola FE, Martínez-Borrego AC, López-Herrero F. Uveitis and serous retinal detachment secondary to systemic dabrafenib and trametinib. Arch Soc Esp Oftalmol. Sep, 2018;93(9):458–462. doi:10.1016/j.oftal.2018.01.008.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.